WANG Ran, CUI Guoli, LI Yajiang. Values of serum endothelial cell specific molecule-1 and visceral adipose tissue-derived serine protease inhibitor levels in the diagnosis of type 2 diabetic macroangiopathy[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 103-106. DOI: 10.7619/jcmp.20201470
Citation: WANG Ran, CUI Guoli, LI Yajiang. Values of serum endothelial cell specific molecule-1 and visceral adipose tissue-derived serine protease inhibitor levels in the diagnosis of type 2 diabetic macroangiopathy[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 103-106. DOI: 10.7619/jcmp.20201470

Values of serum endothelial cell specific molecule-1 and visceral adipose tissue-derived serine protease inhibitor levels in the diagnosis of type 2 diabetic macroangiopathy

More Information
  • Received Date: December 26, 2020
  • Available Online: March 03, 2021
  • Published Date: March 03, 2021
  •   Objective  To investigate the clinical significance of serum endothelial cell specific molecule-1 (Endocan-1)and visceral adipose tissue-derived serine proteaseinhibitor (Vaspin) levels in the diagnosis of type 2 diabetes mellitus (T2DM) macroangiopathy (MVC).
      Methods  Seventy-two patients were selected and divided into T2DM group (n=36) and MVC group (n=36) according to whether they were complicated with macrovascular disease. In addition, 36 healthy subjects were selected as control group. The levels of Endocan-1 and Vaspin in serum of the three groups were determined by enzym-linked immunosorbent assay.
      Results  The levels of serum Endocan-1 in T2DM group and MVC group were significantly higher than that in the control group, and the level of serum endocan-1 in MVC group was significantly higher than that in T2DM group (P < 0.05). The level of Vaspin in MCV group was significantly lower than that in T2DM group and control group, and the level of Vaspin in T2DM group was significantly higher than that in control group (P < 0.05). Endocan-1 was positively correlated with T2DM complicated with macrovascular disease, while Vaspin was negatively correlated with T2DM complicated with macrovascular disease. The areas under curve (AUC) of Endocan-1 and Vaspin in MVC group were 0.910% and 0.720%, and the cut-off values were 1 410 pg/mL and 890 pg/mL, respectively. The sensitivity was 81% and 85%, and the specificity was 76% and 73%, respectively.
      Conclusion  Serum Endocan-1 and Vaspin levels are correlated with T2DM macroangiopathy, which can be used as the diagnostic basis for T2DM macroangiopathy.
  • [1]
    李丽疆, 郭三敏, 孙健, 等. 非对称二甲基精氨酸、血管内皮生长因子与2型糖尿病合并大血管病变的相关性研究[J]. 中国糖尿病杂志, 2019, 27(1): 42-45. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGTL201901010.htm
    [2]
    ZHONG C, YANG X, FENG Y, et al. Trained immunity: an underlying driver of inflammatory atherosclerosis[J]. Front Immunol, 2020, 11: 284. doi: 10.3389/fimmu.2020.00284
    [3]
    ÇIMEN T, EFE T H, AKYEL A, et al. Human endothelial cell-specific molecule-1 (endocan) and coronary artery disease and microvascular angina[J]. Angiology, 2016, 67(9): 846-853. doi: 10.1177/0003319715625827
    [4]
    HUANG X, CHEN C, WANG X, et al. Prognostic value of endocan expression in cancers: evidence from meta-analysis[J]. Oncotargets Ther, 2016, 9: 6297-6304. doi: 10.2147/OTT.S110295
    [5]
    楚轶, 卢少平, 冯品, 等. 血清endocan质量浓度与急性心肌梗死的相关性研究[J]. 现代医学, 2015, 43(5): 588-591. https://www.cnki.com.cn/Article/CJFDTOTAL-TDYX201505015.htm
    [6]
    KLESSENS C Q F, ZANDBERGEN M, WOLTERBEEK R, et al. Macrophages in diabetic nephropathy in patients with type 2 diabetes[J]. Nephrol Dial Transplant, 2017, 32(8): 1322-1329.
    [7]
    EL-MESALLAMY H O, KASSEM D H, EL-DEMERDASH E, et al. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus[J]. Metabolism, 2011, 60(1): 63-70. doi: 10.1016/j.metabol.2010.04.008
    [8]
    FENG R N, LI Y C, WANG C, et al. Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: a meta-analysis[J]. Diabetes Res Clin Pract, 2014, 106(1): 88-94. doi: 10.1016/j.diabres.2014.07.026
    [9]
    VAN J A, SCHOLEY J W, KONVALINKA A. Insights into diabetic kidney disease using urinary proteomics and bioinformatics[J]. J Am Soc Nephrol, 2017, 28(4): 1050-1061. doi: 10.1681/ASN.2016091018
    [10]
    SATHYASEELAN A J. Assessment of serum VASPIN levels among type 2 diabetes mellitus patients with or without acute coronary syndrome[J]. J CLINICAL DIAGNOSTIC RESEARCH, 2016, 10(12): BC07-BC10. http://europepmc.org/abstract/MED/28208842
    [11]
    YANG W, LI Y, TIAN T, et al. Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications[J]. BMC Endocr Disord, 2017, 17(1): 67-69. doi: 10.1186/s12902-017-0216-0
    [12]
    吕英俊, 余平, 陈奕, 等. 冠状动脉粥样硬化性心脏病患者血清adropin蛋白与炎性指标水平变化及相关性分析[J]. 重庆医学, 2019, 48(23): 4116-4118. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYY201805021.htm

Catalog

    Article views (330) PDF downloads (19) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return